Patent · US Active

Fused tricyclic heterocycle compounds and therapeutic uses thereof

US11535633B2 · kind B2 · utility

1Cited by

1References

33Claims

0Family size

Assignees

Inventors

Dong Liu · Natick, US
Lei Chen · Singapore, SG
Linghang Zhuang · Doylestown, US
Puhui Li · Plainsboro, US
Xinzhu Zhang · Franklin Park, US
Chunying Song · Ottawa, CA
Matthew S. Miller · Newtown, US
Qiyue Hu · Shanghai, CN
Yuna Yan · Shanghai, CN
Feng He · Nanhu, CN
Weikang Tao · Shanghai, CN

Key dates

Filing date	Jun 28, 2019
Grant date	Dec 27, 2022
Priority date	—
Expiry date	Jun 28, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application discloses a new class of fused tricyclic heterocycles of formula (I), preparation methods thereof, pharmaceutical compositions comprising these compounds, and pharmaceutically acceptable salts, solvates, or prodrugs thereof, and their uses for the treatment of diseases in which modulation of STING is beneficial, for example, cancers, pre-cancerous disorders, and viral infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.